Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine as Adjunct Therapy for Type 2 Diabetes in Pregnancy
NCT06319560Recruiting
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Mar 2024
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of hydroxychloroquine in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Universiti Kebangsaan Malaysia. Primary endpoints: Serum Glycated Haemoglobin, Serum Fructosamine and 3 more. Started Mar 2024; status: recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT06319560.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06319560.